See‐Chun Phan
Impact in
-
- Breast Cancer Treatment Studies
-
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Co-authors
- Aditya Bardia (1 shared paper)Adam Brufsky (1 shared paper)Lisa A. Carey (1 shared paper)Scott J. Hofsess (1 shared paper)Sara Alsterlind Hurvitz (1 shared paper)Javier Cortés (1 shared paper)Hope S. Rugo (1 shared paper)Johanna C. Bendell (2 shared papers)
- Journals
- Blood (2 papers)Clinical Colorectal Cancer (1 paper)The Oncologist (1 paper)Clinical Pharmacology & Therapeutics (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesBelgiumSpain
In The Last Decade
See‐Chun Phan
11 papers receiving 290 citations
See‐Chun Phan's Hit Papers
Peers
Comparison fields: 5 of 35
- Cancer Research 87
- Oncology 108
- Pulmonary and Respiratory Medicine 69
- Pathology and Forensic Medicine 35
- Radiology, Nuclear Medicine and Imaging 37
Countries citing papers authored by See‐Chun Phan
This map shows the geographic impact of See‐Chun Phan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by See‐Chun Phan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites See‐Chun Phan more than expected).
Fields of papers citing papers by See‐Chun Phan
This network shows the impact of papers produced by See‐Chun Phan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by See‐Chun Phan. The network helps show where See‐Chun Phan may publish in the future.
Co-authors
The 25 scholars most cited alongside See‐Chun Phan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression Hit paper breakdown → | 2024 | 133 |
| 2 | 2017 | 51 | |
| 3 | 2013 | 29 | |
| 4 | 2015 | 25 | |
| 5 | 2009 | 17 | |
| 6 | 1996 | 13 | |
| 7 | 2024 | 11 | |
| 8 | 2005 | 10 | |
| 9 | 1999 | 2 | |
| 10 | 2004 | 2 | |
| 11 | 2005 | 1 |
About See‐Chun Phan
See‐Chun Phan is a scholar working on Genetics, Oncology, Cancer Research, Pathology and Forensic Medicine and Toxicology, having authored 11 papers that have together received 294 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (3 papers), Glioma Diagnosis and Treatment (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Breast Cancer Treatment Studies (2 papers), Signaling Pathways in Disease (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (87 citations), Oncology (108 citations), Pulmonary and Respiratory Medicine (69 citations), Pathology and Forensic Medicine (35 citations) and Radiology, Nuclear Medicine and Imaging (37 citations). See‐Chun Phan has collaborated with scholars based in United States, Belgium and Spain. Frequent co-authors include Aditya Bardia, Adam Brufsky, Lisa A. Carey, Scott J. Hofsess, Sara Alsterlind Hurvitz, Javier Cortés, Hope S. Rugo, Johanna C. Bendell, Kevin Punie and Sara Tolaney. Their work appears in journals such as Blood, Clinical Colorectal Cancer, The Oncologist, Clinical Pharmacology & Therapeutics and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.